| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
| 02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
| 02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073723A2 Ste20-related protein kinases |
| 02/07/2001 | EP1073720A2 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects |
| 02/07/2001 | EP1073719A2 Process for obtaining stem cells |
| 02/07/2001 | EP1073718A1 Nucleic acids that control seed and fruit development in plants |
| 02/07/2001 | EP1073717A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
| 02/07/2001 | EP1073716A2 Improvements in or relating to separation processes |
| 02/07/2001 | EP1073715A1 Methionin containing animal cell culture medium and its use |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073670A1 Optimization of pest resistance genes using dna shuffling |
| 02/07/2001 | EP1073464A1 Monoclonal antibodies with reduced immunogenicity |
| 02/07/2001 | EP1073460A1 Nucleic acid encoding hyaluronan synthase and methods of use |
| 02/07/2001 | EP1073448A1 Fertility improving composition and application thereof |
| 02/07/2001 | EP1073420A2 Specially devised neuronal implants for reconstruction of damaged central nervous system |
| 02/07/2001 | CN1283235A Method for producing complex DNA methylation fingerprints |
| 02/07/2001 | CN1283233A Variant loxP sequences and application of the same |
| 02/07/2001 | CN1283231A Moldified vitamin K-dependent polypeptides |
| 02/07/2001 | CN1283230A Desaturated enzyme |
| 02/07/2001 | CN1283229A Promoter from ashbya gossypii |
| 02/07/2001 | CN1283225A Pectin degrading alcohol from i(Bacillus licheniformis) |
| 02/07/2001 | CN1283223A Preparation of cells for production of biologicals |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1283082A Carbohydrate oxidase and use thereof in baking |
| 02/06/2001 | US6184443 Cold-inducible and tuber-specific promoter sequence from potato α-amylase gene |
| 02/06/2001 | US6184440 Transgenic plants of altered morphology |
| 02/06/2001 | US6184359 Humanized monoclonal antibody which preferentially binds lymphocyte polypeptide; for treatment of toxicity in tumor therapy; for the treatment and prevention of gastrointestinal and viral diseases |
| 02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184043 Monitoring and counting preferential aggregations in suspension; coat paramagnetic particles or beads with antibody, mix coated particles with preferential aggregates, incubate, monitor and count aggregations after incubation |
| 02/06/2001 | US6184038 Transport proteins and their uses |
| 02/06/2001 | US6184035 Modulation of cellular differentiation in bone associated tissues; culturing muscles tissues under preferential oxygen environment and monitoring development |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184030 Biologically-active polymers |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6184020 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 02/06/2001 | US6184016 Polypeptides having prenylcysteine carboxyl methyltransferase activity or inhibiting activity |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183992 Recombinant production by constructing and using expression vector having fusion gene coding for negatively charged acidic peptide with two cysteines and positively charged basic antimicrobial peptide; minimizes effect of microbiocide |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183990 Compounds |
| 02/06/2001 | US6183974 Transfecting specific cells which express urokinase plasminogen activator and have suppressed gs signaling of enzyme with expression vector coding for g protein coupled receptor, contacting with compound, measuring enzyme activity |
| 02/06/2001 | US6183962 Nucleotide sequence of cardiovascular system associated protein kinase; antisense agents; recombinant expression vectors; host cells for culture production; diagnosis and treatment of cardiovascular disorders; probes; primers; kits |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183740 Recombinant bacterial phytases and uses thereof |
| 02/06/2001 | US6183737 Bonding of cartilage pieces using isolated chondrocytes and a biological gel |
| 02/06/2001 | US6183735 Immortalized retinal pigmentary epithelial cell lines and their applications |
| 02/06/2001 | US6183734 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2013544C Retinoblastoma gene product antibodies and uses therefor |
| 02/05/2001 | CA2311201A1 Ests and encoded human proteins |
| 02/05/2001 | CA2309313A1 Stimulation of the immune response by human dendritic cell manipulation |
| 02/01/2001 | WO2001007917A1 Determining antibodies to ny-eso-1 in cancer patients |
| 02/01/2001 | WO2001007911A2 A novel method for the improved isolation of a target cell population |
| 02/01/2001 | WO2001007891A2 Miniaturized cell array methods and apparatus for cell-based screening |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007637A2 Conditionally controlled, attenuated hiv vaccine |
| 02/01/2001 | WO2001007636A2 Maize dna ligase ii orthologue and uses thereof |
| 02/01/2001 | WO2001007632A1 Method for obtaining isogenic transgenic lines |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007627A1 Drosophila recombination-associated protein and methods for use |
| 02/01/2001 | WO2001007618A1 Homeobox genes encoding proteins participating in differentiation |
| 02/01/2001 | WO2001007616A1 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007607A2 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 02/01/2001 | WO2001007596A1 Arabidopsis thaliana cyclic nucleotide-gated ion channel/dnd genes; regulators of plant disease resistance and cell death |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007585A1 Electrical impedance tomography to control electroporation |
| 02/01/2001 | WO2001007584A1 Controlled electroporation and mass transfer across cell membranes |
| 02/01/2001 | WO2001007582A1 Three-dimensional cell incubation media and method for incubating cells by using the same |
| 02/01/2001 | WO2001007572A2 Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system |
| 02/01/2001 | WO2001007571A1 Means and methods for nucleic acid transfer |
| 02/01/2001 | WO2001007569A1 Protecting pancreatic beta-cells during islet isolation; assessing islet viability and candidate diabetes drugs after islet isolation |
| 02/01/2001 | WO2001007568A2 Muscle cells and their use in cardiac repair |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007472A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007466A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007069A1 In vivo induction for enhanced function of isolated hepatocytes |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2001007059A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2001 | WO2001007021A2 Process for the improvement of spermatozoa fertilization activity |
| 02/01/2001 | WO2001006989A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |